(1S*,3R*,7R*,9S*,14R*)-7-METHYL-3-PENTYL-2,8,13-TRIOXATRICYCLO-[8.5.0.0(9,14)]-PENTADEC-10-ENE-12-ONE
Compound with spectra: 1 NMR
![(1S*,3R*,7R*,9S*,14R*)-7-METHYL-3-PENTYL-2,8,13-TRIOXATRICYCLO-[8.5.0.0(9,14)]-PENTADEC-10-ENE-12-ONE](/api/compound/Ci9pytb71N0.png?ph=true&h=300&w=458 "(1S*,3R*,7R*,9S*,14R*)-7-METHYL-3-PENTYL-2,8,13-TRIOXATRICYCLO-[8.5.0.0(9,14)]-PENTADEC-10-ENE-12-ONE")
| SpectraBase Compound ID | Ci9pytb71N0 |
|---|---|
| InChI | InChI=1S/C18H28O4/c1-3-4-5-7-13-8-6-11-18(2)16(20-13)12-15-14(22-18)9-10-17(19)21-15/h9-10,13-16H,3-8,11-12H2,1-2H3/t13-,14+,15-,16+,18-/m1/s1 |
| InChIKey | MJMNQLNCDWOTDL-RIUYPTKQSA-N |
| Mol Weight | 308.42 g/mol |
| Molecular Formula | C18H28O4 |
| Exact Mass | 308.198759 g/mol |
| Enantiomer InChIKey | MJMNQLNCDWOTDL-WXQHOCMDSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
6S-[1,2-DI-ACETYLOXY-3-(CHLOROACETYLOXY)-HEPTANYL]-5S-ACETYLOXY-5,6-DIHYDRO-2H-PYRAN-3-ONE
2-Butenoic acid, 3-methyl-5-[tetrahydro-7'-(2-oxoethyl)spiro[cyclohexane-1,2'-[4H-1,3]dioxolo[4,5-c]pyran]-4'-yl]-, 1,1-dimethylethyl ester, [3'aS-[3'a.alpha.,4'.alpha.(E),7'.alpha., 7'a.alpha.]]-
Epothylone a-9
Methyl 2,3,4-tri-O-acetyl-6-O-tritylhexopyranoside
METHYL 2,3,4-TRI-O-ACETYL-6-O-TRITYL-ALPHA-D-MANNOPYRANOSIDE
CRASSUMOL-F
METHYL 2,3-DI-O-ACETYL-4-O-(2,3,5-TRI-O-ACETYL-ALPHA-L-ARABINOFURANOSYL)-BETA-L-ARABINOPYRANOSE
METHYL 2,3-DI-O-ACETYL-4-O-(2,3,5-TRI-O-ACETYL-ALPHA-L-ARABINOFURANOSYL)-BETA-D-XYLOPYRANOSE
2H-1-Benzopyran-4a(5H)-ol, hexahydro-2,5,5,8a-tetramethyl-, acetate
EUPALMERIN;(7E,1S,3S,4R,12S,13R,14R)-13-HYDROXY-3,4-EPOXYCEMBRA-7,15-DIEN-16,14-OLIDE
| Title | Journal or Book | Year |
|---|---|---|
| Development of an Approach to the Synthesis of the ABC Ring System of Hemibrevetoxin B | Organic Letters | 2006 |